Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) and SpaceX offer two very different August trades. Rocket Lab just posted a record Q1 and reports again after the close on August 10, 2026. SpaceX only recently listed on June 12, 2026, which means it lacks the comparable public earnings history that drives short-term catalyst trading.
Rocket Lab’s Backlog Is Doing the Heavy Lifting
Peter Beck’s Q1 FY2026 delivered revenue of $200.35 million, up 63.5% year over year, beating consensus by 5.77%. The loss narrowed to -$0.07 per share against a -$0.0787 estimate. Service revenue jumped 74.4%, a sign the space systems franchise is starting to carry real weight beyond launch.
The backlog reached $2.2 billion, up 20.2% sequentially, with 31 new Electron and HASTE agreements plus 5 Neutron missions signed in a single quarter. That is more contract volume than all of 2025. Since the earnings report, Rocket Lab has added a $397 million Space Force SB-AMTI “Flatellite” award and a $266 million Air Force suborbital contract for 12 launches.
SpaceX by contrast operates at a scale Rocket Lab cannot approach: Falcon 9 cadence, Starlink’s recurring subscription revenue, and Starship development. It just does not offer investors the same tight, testable catalyst calendar.
| Business Driver | Rocket Lab | SpaceX |
| Growth Engine | Electron cadence, Neutron debut, space systems | Falcon 9 dominance, Starlink subscriptions |
| Backlog Visibility | $2.2B disclosed | Not publicly disclosed |
| August Catalyst | Earnings Aug. 10, Neutron progress | Limited post-IPO disclosure |
One Trades Catalysts, One Trades Scale
Beck told investors “Rocket Lab’s tailwinds are strong. We’re already embedded in the most demanding and significant space programs of our generation.” He has also framed Rocket Lab’s approach as “rapid architectural innovation and capital efficiency” rather than SpaceX-style heavy capex. That is the whole pitch: smaller, faster, government-anchored.
The trade-off is severe volatility. RKLB is down roughly 50% since the SpaceX listing, yet it also ripped 27.53% in the week ended August 7 as contract news landed. SpaceX shares trade on brand and scale narratives, not on quarterly beats.
August 10 Is the Trade
The Q2 setup is aggressive. Management guided to revenue of $225 million to $240 million, and the Street sits at $235.97 million with a $0.08 loss. I will be listening for Neutron test-firing detail, Iridium acquisition financing, and any Golden Dome expansion. Median analyst target is $120.
Why I Lean Rocket Lab for a Tactical August
For a pure August window, Rocket Lab looks like the more actionable name. The catalyst stack is real, liquidity is deep, and the setup into the report gives active traders a defined event. Worth weighing against that: $362.8 million in insider selling over the last three months, and dilution from the $450 million ATM raise. For readers focused on a multi-year compounder with an operational moat, SpaceX carries the scale narrative. For a 30-day event window, RKLB is where the identifiable levers sit.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks